Linear Low - Dose Extrapolations

Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification

Volumn , Issue , 2010, Pages 615-635

  Dourson, Michael ^a   Haber, Lynne ^a  

^a Toxicology Excellence for Risk Assessment   (United States)

Author keywords

Biologically based dose response (BBDR) model capturing multiple MOAs; General approaches for quantifying cancer risks linear low dose extrapolations; Rationale for linear linear dose dose extrapolation linear dose response for multiple systems' mutations

Indexed keywords

EID: 84885993803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470622728.ch24     Document Type: Chapter

References (50)

1. American Conference of Governmental Industrial Hygienists (ACGIH) . ( 2006 ). TLVs and BEIs: Based on the documentation of the threshold limit values for chemical substances and physical agents & bioassays exposures indices . Appendix E. Threshold limit values for mixtures. Cincinnati, OH.
2. Andersen , M. E. , Conolly , R. B. , and Gaylor , D. W. ( 2003 ). Thresholds of carcinogenicity in the ED01 study . Toxicol Sci 74 ( 2 ), 486-487 .
3. Butterworth , B. E. , and Bogdanffy , M. S. ( 1999 ). A comprehensive approach for integration of toxicity and cancer risk assessments . Regul Toxicol Pharmacol 29 , 23-36 .
4. CIIT ( 2009 ). International Toxicity Estimates for Risk (ITER) IPRV entry for CIIT ' s formaldehyde . Accessed at http://toxnet.nlm.nih.gov .
5. Calabrese , E. J. ( 2009 ). The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment . Arch Toxicol 83 , 203-225 .
6. Conolly , R. B. , Kimbell , J. S. , Janszen , D. , Schlosser , P. M. , Kalisak , D. , Preston , J. , and Miller , F. J. ( 2004 ). Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically - motivated computational modeling of a combined rodent and human dataset . Toxicol Sci 82 , 279-296 .
7. Crump , K. S. , Hoel , D. G. , Langley , C. H. , and Peto , R. ( 1976 ). Fundamental carcinogenic processes and their implications for low dose risk assessment . Cancer Res 36 , 2973-2979 .
8. Dolan , D. , Naumann , B. , Sargent , E. , Maier , A. , and Dourson , M. ( 2005 ). Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations . Regul Toxicol Pharmacol 43 , 1-9 .
9. Doull , J. ( 2003 ). The " Red Book " and other risk assessment milestones . Hum Ecol Risk Assess 9 , 1229-1238 .
10. Dourson , M. L. , Hertzberg , R. , Allen , B. , Haber , L. , Parker , A. , Kroner , O. , Maier , A. , and Kohrman , M. ( 2008 ). Evidence - based dose response assessment for thyroid tumorigenesis from acrylamide . Regul Toxicol Pharmacol 52 ( 3 ), 264-289 .
11. EPA ( 1986 ). Guidelines for the health risk assessment of chemical mixtures . EPA/630/R - 98/002 .
12. EPA ( 1996 ). Proposed guidelines for carcinogen risk assessment . Office of Research and Development, Washington, D.C. EPA/600/P - 92/003C .
13. EPA ( 2000 ). Supplementary guidance for conducting health risk assessment of chemical mixtures . EPA/630/R - 00/002 .
14. EPA ( 2005 ). Guidelines for carcinogen risk assessment . EPA/630/P - 03/001B .
15. EPA ( 2007 ). Framework for determining a mutagenic mode of action for carcinogenicity (external review draft) . EPA 120/R - 07/002 - A .
16. EPA ( 2009a ). IRIS entry for N - nitrosodimethylamine . Accessed at http://www.epa.gov/NCEA/iris/subst/0045.htm .
17. EPA ( 2009b ). IRIS entry for perchlorate . Accessed at http://www.epa.gov/NCEA/iris/subst/1007.htm .
18. EPA ( 2009c ). IRIS entry for PCBs . Accessed at http://www.epa.gov/NCEA/iris/subst/0294.htm .
19. EPA ( 2009d ). Overview summary of toxicological, chemical, and statistical criteria for defi ning suffi cient similarity for use in the risk assessment of chemical mixtures . Published as a series of papers in J Toxicol Environ Health A 72 , 429-504 .
20. Gaddum , J. H. ( 1945 ). Lognormal distributions . Nature 156 ( 3964 ), 463-466 .
21. Guyton , K. Z. , Kyle , A. D. , Aubrecht , J. , Cogliano , V. J. , Eastmond , D. A. , Jackson , M. , Keshava , N. , Sandy , M. S. , Sonawane , B. , Zhang , L. , Waters , M. D. , and Smith , M. T. ( 2009 ). Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches . Mutat Res 681 ( 2-3 ), 230-240 .
22. Haseman , J. K. ( 2003 ). An alternative perspective: A critical evaluation of the Waddell threshold extrapolation model in chemical carcinogenesis . Toxicol Pathol 31 ( 5 ), 468-470 .
23. Health Canada ( 2009 ). International toxicity estimates for risk (ITER) entry for Health Canada ' s 1,3 - butadiene . Accessed at http://toxnet.nlm.nih.gov/.
24. Hengstler , J. G. , Bogdanffy , M. S. , Bolt , H. M. , and Oesch , F. ( 2003 ). Challenging dogma: Thresholds for genotoxic carcinogens? The case of vinyl acetate . Annu Rev Pharmacol Toxicol 43 , 485-520 .
25. Heyssel , R. , Brill , A. B. , Woodbury , L. A. , Nishimura , E. T. , Ghose , T. , Hoshino , T. , and Yamasaki , M. ( 1960 ). Leukemia in Hiroshima atomic bomb survivors . Blood 15 ( 3 ), 313-331 .
26. Hoshi , M. , Morimura , K. , Wanibuchi , H. , Wei , M. , Okochi , E. , Ushijima , T. , Takaoka , K. , and Fukushima , S. ( 2004 ). No - observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen . Toxicol Sci 81 , 273-279 .
27. Kirsch-Volders , M. , Aardema , M. , and Elhajouji , A. ( 2000 ). Concepts of threshold in mutagenesis and carcinogenesis . Mutat Res 464 , 3-11 .
28. Koana , T. , Takashima , Y. , Okada , M. O. , Ikehata , M. , Miyakoshi , J. , and Sakai , K. ( 2004 ). A threshold exists in the dose-response relationship for somatic mutation frequency induced by X irradiation of Drosophila . Radiat Res 161 , 391-396 .
29. Kroes , R. , Kleiner , J. , and Renwick , A. ( 2005 ). The threshold of toxicological concern concept in risk assessment . Toxicol Sci 86 ( 2 ), 226-230 .
30. Lehninger , A. L. ( 1975 ). Biochemistry , 2nd edition , Worth Publishers , New York .
31. Lovell , D. P. ( 2000 ). Dose-response and threshold-mediated mechanisms in mutagenesis: Statistical models and study design . Mutat Res 464 , 87-95 .
32. Lutz , W. K. ( 1990 ). Dose-reponse relationship and low dose extrapolation in chemical carcinogenesis . Carcinogenesis 11 ( 8 ), 1243-1247 .
33. Lutz , W. K. ( 1998 ). Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes . Mutat Res 405 ( 2 ), 117-124 .
34. Lutz , W. K. ( 2001 ). Susceptibility differences in chemical carcinogenesis linearize the dose-response relationship: Threshold doses can be defi ned only for individuals . Mutat Res 482 , 71-76 .
35. Lutz , W. K. , Gaylor , D. W. , Conolly , R. B. , and Lutz , R. W. ( 2005 ). Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility . Toxicol Appl Pharmacol 207 , S565-S569 .
36. Meek , M. , Newhook , R. , Liteplo , R. , and Armstrong , V. C. ( 1994 ). Approach to assessment of risk to human health for priority substances under the Canadian environmental protection act . J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 12 ( 2 ), 105-134 .
37. Melnick , R. L. , Kohn , M. C. , and Portier , C. J. ( 1996 ). Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis . Environ Health Perspect 104 ( Suppl 1 ), 123-134 .
38. Moore , M. M. , Heflich , R. H. , Haber , L. T. , Allen , B.C. , Shipp , A. M. , and Kodell , R. L. ( 2008 ). Analysis of in vivo mutation data can inform cancer risk assessment . Regul Toxicol Pharmacol 51 , 151-161 .
39. NAS ( 1977 ). Drinking Water and Health , National Academies Press , Washington, D.C .
40. NAS ( 2008 ). Science and Decisions: Advancing Risk Assessment , National Academies Press , Washington, D.C .
41. Perera , F. P. ( 1988 ). The signifi cance of DNA and protein adducts in human biomonitoring studies . Mutat Res 205 , 255-269 .
42. Rhomberg , L. ( 2008 ). Personal communication with L . Haber of Toxicology Excellence for Risk Assessment ( TERA ).
43. RIVM ( 2009 ). ITER entry for RIVM ' s trichloroethylene . Accessed at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?iter .
44. Rozman , K. K. , Kerecsen , L. , Viluksela , M. K. , Osterle , D. , Deml , E. , Viluksela , M. , Stahl , B. U. , Greim , H. , and Doull , J. ( 1996 ). A toxicologist ' s view of cancer risk assessment . Drug Metab Rev 28 ( 1-2 ), 29-52 .
45. Slikker , W. , Jr , Andersen , M. E. , Bogdanffy , M. S. , Bus , J. S. , Cohen , S. D. , Conolly , R. B. , David , R. M. , Doerrer , N. G. , Dorman , D. C. , Gaylor , D. W. , Hattis , D. , Rogers , J. M. , Woodrow Setzer , R. , Swenberg , J. A. , and Wallace , K. ( 2004a ). Dose-dependent transitions in mechanisms of toxicity . Toxicol Appl Pharmacol 201 ( 3 ), 203-225 .
46. Slikker , W. , Jr , Andersen , M. E. , Bogdanffy , M. S. , Bus , J. S. , Cohen , S. D. , Conolly , R. B. , David , R. M. , Doerrer , N. G. , Dorman , D. C. , Gaylor , D. W. , Hattis , D. , Rogers , J. M. , Woodrow Setzer , R. , Swenberg , J. A. , and Wallace , K. ( 2004b ). Dose-dependent transitions in mechanisms of toxicity: Case studies . Toxicol Appl Pharmacol 201 ( 3 ), 226-294 .
47. Sofuni , T. , Hayashi , M. , Nohmi , T. , Matsuoka , A. , Yamada , M. , and Kamata E. ( 2000 ). Semiquantitative evaluation of genotoxic activity of chemical substances and evidence for a biological threshold of genotoxic activity . Mutat Res 464 , 97-104 .
48. Swenberg , J. A. , Fryar-Tita , E. , Jeong , Y. C. , Boysen , G. , Starr , T. , Walker , V. E. , and Albertini , R. J. ( 2008 ). Biomarkers in toxicology and risk assessment: Informing critical dose response assessment relationships . C hem Res Toxicol 21 , 253-265 .
49. Waddell , W. J. ( 2003a ). Thresholds in Chemical Carcinogenesis: What are animal experiments telling us?. Toxicol Pathol 31 ( 3 ), 260-262 .
50. Waddell , W. J. ( 2003b ). Reply . Toxicol Pathol 31 ( 6 ), 712-713